Assessment of your health goals, what you want to achieve (energy, immunity, skin health, recovery) 2
Deficiencies in key nutrients can impair metabolic function in ways that contribute to stalls
Glucagon-like peptide-1 (GLP1) regulates blood sugar and appetite Glucose-dependent insulinotropic polypeptide (GIP) regulates insulin Glucagon controls blood sugar levels Together, these multiple pathways are all involved in appetite, satiety and digestive speed
This provides some therapeutic buffer, though effects on blood sugar control and appetite suppression gradually diminish as drug levels decline
At 5 mg, average weight loss was 16% of body weight
Gastrointestinal side effects nausea, vomiting, reduced appetite are the most common adverse events and may influence preferred dosing time